Advancing Rare Disease Development

Bring rare disease treatments to market, faster — it’s the goal of every biopharmaceutical company. In this report, Parexel and industry experts share insights for increasing speed and efficiency in the drug development process supported by a thorough understanding of the illness from the perspective of patients and caregivers. You’ll find timely analysis and actionable advice on topics most critical to rare disease drug development and payer reimbursement, including best practices for integrating strategies that address scientific, regulatory, and market access considerations.